Pregnancy after breast cancer in patients with germline BRCA mutations

Matteo, Md, Phd Lambertini, Lieveke, Msc, Phd Ameye, Anne Sophie, Md, Phd Hamy, Anna, Md Zingarello, Philip D.,md Poorvu, Estela, Msc Carrasco, Albert, Md, Msc Grinshpun, Sileny, Md Han, Christine, Md, Phd Rousset-Jablonski, Alberta, Md Ferrari, Shani, Mbbs, Msc Paluch-Shimon, Laura, Md Cortesi, Claire, Md Senechal, Gianmaria, Md Miolo, Katarzyna, Md Pogoda, Jose Alejandro, Md, Phd Pérez-Fidalgo, Laura, Md De Marchis, Riccardo, Md, Phd Ponzone, Luca, Md Livraghi, Maria, Md, Phd Del Pilar Estevez-DizCynthia, Md, Phd Villarreal-Garza, Maria Vittoria, Md Dieci, Florian, Md, Phd Clatot, Martine, Md, Phd Berlière, Rossella, Md Graffeo, Luis, Md, Phd Teixeira, Octavi, Md, Phd Córdoba, Amir, Md, Phd Sonnenblick, Helena Luna, Md Pais, Michail, Md, Phd Ignatiadis, Marianne, Msc Paesmans, Ann H.,.Md, Mph Partridge, Olivier, Md, Msc Caron, Claire, Md, Msc Saule, Lucia, Md Del Mastro, Fedro A.,.Md, Phd Peccatori, Hatem A. Azim

    Résultats de recherche: Contribution à un journalArticle 'review'Revue par des pairs

    67 Citations (Scopus)

    Résumé

    PURPOSE Young women with germline BRCA mutations have unique reproductive challenges. Pregnancy after breast cancer does not increase the risk of recurrence; however, very limited data are available in patients with BRCA mutations. This study investigated the impact of pregnancy on breast cancer outcomes in patients with germline BRCA mutations. PATIENTS AND METHODS This is an international, multicenter, hospital-based, retrospective cohort study. Eligible patients were diagnosed between January 2000 and December 2012 with invasive early breast cancer at age ≤ 40 years and harbored deleterious germline BRCA mutations. Primary end points were pregnancy rate, and disease-free survival (DFS) between patients with and without a pregnancy after breast cancer. Pregnancy outcomes and overall survival (OS) were secondary end points. Survival analyses were adjusted for guaranteetime bias controlling for known prognostic factors. RESULTS Of 1,252 patients with germline BRCA mutations (BRCA1, 811 patients; BRCA2, 430 patients; BRCA1/2, 11 patients) included, 195 had at least 1 pregnancy after breast cancer (pregnancy rate at 10 years, 19%; 95%CI, 17% to 22%). Induced abortions and miscarriages occurred in 16 (8.2%) and 20 (10.3%) patients, respectively. Among the 150 patients who gave birth (76.9%; 170 babies), pregnancy complications and congenital anomalies occurred in 13 (11.6%) and 2 (1.8%) cases, respectively. Median follow-up from breast cancer diagnosis was 8.3 years. No differences in DFS (adjusted hazard ratio [HR], 0.87; 95%CI, 0.61 to 1.23; P5.41) or OS (adjusted HR, 0.88; 95% CI, 0.50 to 1.56; P = .66) were observed between the pregnancy and nonpregnancy cohorts. CONCLUSION Pregnancy after breast cancer in patients with germline BRCA mutations is safe without apparent worsening of maternal prognosis and is associated with favorable fetal outcomes. These results provide reassurance to patients with BRCA-mutated breast cancer interested in future fertility.

    langue originaleAnglais
    Pages (de - à)3012-3023
    Nombre de pages12
    journalJournal of Clinical Oncology
    Volume38
    Numéro de publication26
    Les DOIs
    étatPublié - 10 sept. 2020

    Contient cette citation